These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15981957)
21. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925 [TBL] [Abstract][Full Text] [Related]
22. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis. Milovanovic JR; Jankovic SM Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493 [TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients. Deleu D; Aarons L; Ahmed IA Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340 [TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of carbamazepine in adults with epilepsy. Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146 [TBL] [Abstract][Full Text] [Related]
25. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication. Kong ST; Lim SH; Chan E; Ho PC J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245 [TBL] [Abstract][Full Text] [Related]
26. [NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics]. Rui JZ; Cai MH; Chu XM; Chen G Yao Xue Xue Bao; 1995; 30(3):172-8. PubMed ID: 7639079 [TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400 [TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics and pharmacogenetics of imatinib in children and adults. Petain A; Kattygnarath D; Azard J; Chatelut E; Delbaldo C; Geoerger B; Barrois M; Séronie-Vivien S; LeCesne A; Vassal G; Clin Cancer Res; 2008 Nov; 14(21):7102-9. PubMed ID: 18981009 [TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of carbamazepine in Singapore epileptic patients. Chan E; Lee HS; Hue SS Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016 [TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors. Guo F; Letrent SP; Sharma A Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315 [TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults. Reith DM; Hooper WD; Parke J; Charles B J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):79-92. PubMed ID: 11253616 [TBL] [Abstract][Full Text] [Related]
32. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data. Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults. Chien S; Bialer M; Solanki B; Verhaeghe T; Doose DR; Novak G; Yao C Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of theophylline population pharmacokinetics in adult hospitalized patients using NONMEM analysis]. Li Z; Chen G Zhongguo Yao Li Xue Bao; 1994 May; 15(3):267-70. PubMed ID: 7976385 [TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotan. Mondick JT; Oo C; Patel D; Fujitani T; Shimizu K; Barrett JS Am J Ther; 2009; 16(2):106-15. PubMed ID: 19300037 [TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics of albendazole in patients with neurocysticercosis. Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532 [TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma. Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931 [TBL] [Abstract][Full Text] [Related]
38. A model for the determination of carbamazepine clearance in children on mono- and polytherapy. Gray AL; Botha JH; Miller R Eur J Clin Pharmacol; 1998 Jun; 54(4):359-62. PubMed ID: 9696965 [TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of valproate in Chinese children with epilepsy. Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957 [TBL] [Abstract][Full Text] [Related]